Fierce Pharma Mix Logo.png Fierce Pharma Mix Logo.png
Webinar

Changing Diagnosis, Referral and Treatment: What Predictive Medicine Means for Pharma

ET
60 Minutes

Medicine is rapidly shifting from decisions made on population averages to highly individual probabilities. AI capabilities coupled with real-world data are now allowing for point-of-care estimation of a patient's likelihood of having a disease, progressing, responding to therapy, and being hospitalized. Meanwhile, value-based payment, quality incentives, and shrinking encounter time are accelerating adoption.

This session will cover:

  • What predictive medicine is
  • Which incentives are driving clinical adoption
  • How it rewires the patient journey
  • What it means for pharma

It will explore the implications for targeting, HCP engagement and medical education, evidence generation and label expansion, brand forecasting, and where commercial and medical affairs teams should be building capabilities today.

Speakers

0

Dr. Rich Gliklich

Founder
OM1

Dr. Richard Gliklich brings decades of experience in outcomes measurement, real world evidence and prediction. He is senior editor of the AHRQ handbook, Registries for Evaluating Patient Outcomes: A User's Guide and led HHS’ Outcomes Measures Framework initiative. Dr. Gliklich is also a researcher and practicing clinician at Harvard and holds more than a dozen patents in the area of AI and predictive outcomes. 

Register here!

Already registered? Click here to login.
Date/Time:
ET